Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)

Boyd G, Morice AH, Pounsford JC, Siebert M, Peslis N, Crawford C.

Eur Respir J. 1997 Apr;10(4):815-21. Erratum in: Eur Respir J 1997 Jul;10(7):1696.

PMID:
9150318
[PubMed - indexed for MEDLINE]
Free Article
2.

Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium.

van Noord JA, de Munck DR, Bantje TA, Hop WC, Akveld ML, Bommer AM.

Eur Respir J. 2000 May;15(5):878-85.

PMID:
10853852
[PubMed - indexed for MEDLINE]
Free Article
3.

A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.

Broseghini C, Testi R, Polese G, Tosatto R, Rossi A.

Pulm Pharmacol Ther. 2005;18(2):103-8. Epub 2005 Jan 7.

PMID:
15649852
[PubMed - indexed for MEDLINE]
5.

The addition of salmeterol 50 microg bid to anticholinergic treatment in patients with COPD: a randomized, placebo controlled trial. Chronic obstructive pulmonary disease.

Chapman KR, Arvidsson P, Chuchalin AG, Dhillon DP, Faurschou P, Goldstein RS, Kuipers AF; International study group.

Can Respir J. 2002 May-Jun;9(3):178-85.

PMID:
12068339
[PubMed - indexed for MEDLINE]
6.

Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. SLMT02 Italian Study Group.

Di Lorenzo G, Morici G, Drago A, Pellitteri ME, Mansueto P, Melluso M, Norrito F, Squassante L, Fasolo A.

Clin Ther. 1998 Nov-Dec;20(6):1130-48.

PMID:
9916607
[PubMed - indexed for MEDLINE]
7.

Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.

Jarvis B, Markham A.

Drugs Aging. 2001;18(6):441-72. Review.

PMID:
11419918
[PubMed - indexed for MEDLINE]
9.

Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease.

Grove A, Lipworth BJ, Reid P, Smith RP, Ramage L, Ingram CG, Jenkins RJ, Winter JH, Dhillon DP.

Thorax. 1996 Jul;51(7):689-93.

PMID:
8882074
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.

Cazzola M, Di Perna F, Noschese P, Vinciguerra A, Calderaro F, Girbino G, Matera MG.

Eur Respir J. 1998 Jun;11(6):1337-41.

PMID:
9657576
[PubMed - indexed for MEDLINE]
Free Article
11.

Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.

Cazzola M, Calderaro F, Califano C, Di Pema F, Vinciguerra A, Donner CF, Matera MG.

Eur J Clin Pharmacol. 1999 Jan;54(11):829-33.

PMID:
10027655
[PubMed - indexed for MEDLINE]
12.
13.
14.

[The effect of salmeterol in the treatment of smokers with chronic obstructive lung disease].

Ulrik CS.

Ugeskr Laeger. 1996 Jun 17;158(25):3604-7. Danish.

PMID:
8693619
[PubMed - indexed for MEDLINE]
15.

Salmeterol plus theophylline combination therapy in the treatment of COPD.

ZuWallack RL, Mahler DA, Reilly D, Church N, Emmett A, Rickard K, Knobil K.

Chest. 2001 Jun;119(6):1661-70.

PMID:
11399688
[PubMed - indexed for MEDLINE]
16.

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.

D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI.

JAMA. 1994 May 11;271(18):1412-6.

PMID:
7909853
[PubMed - indexed for MEDLINE]
17.

Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.

Vestbo J, Pauwels R, Anderson JA, Jones P, Calverley P; TRISTSAN study group.

Thorax. 2005 Apr;60(4):301-4.

PMID:
15790985
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

[Bronchodilator efficacy of combined salmeterol and tiotropium in patients with chronic obstructive pulmonary disease].

Baloira Villar A, VilariƱo Pombo C.

Arch Bronconeumol. 2005 Mar;41(3):130-4. Spanish.

PMID:
15766465
[PubMed - indexed for MEDLINE]
Free Article
19.

Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.

Rennard SI, Anderson W, ZuWallack R, Broughton J, Bailey W, Friedman M, Wisniewski M, Rickard K.

Am J Respir Crit Care Med. 2001 Apr;163(5):1087-92.

PMID:
11316640
[PubMed - indexed for MEDLINE]
20.

A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.

Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K.

Treat Respir Med. 2004;3(3):173-81.

PMID:
15219176
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk